Back to search

Article

Engineering of Primary Human B cells with CRISPR/Cas9 Targeted Nuclease

2018-03-28

Abstract excerpt

B cells offer unique opportunities for gene therapy because of their ability to secrete large amounts of protein in the form of antibody and persist for the life of the organism as plasma cells. Here, we report optimized CRISPR/Cas9 based genome engineering of primary human B cells. Our procedure involves enrichment of CD19 + B cells from PBMCs followed by activation, expansion, and electroporation of CRISPR/Cas9...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a2b0bd72-b452-5a48-8cf0-118a3692577d
DOI
10.1101/290973
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Engineering of Primary Human B cells with CRISPR/Cas9 Targeted NucleaseDOI 10.1101/290973
Select a neighboring publication to make it the new centre.